Medicines: permissions and operating records · France / Switzerland
Cross-border prescription: dispensing evidence record
A cross-border prescription must be examined using both the issuing country and the destination of dispensing. EU recognition rules must not be extended automatically to Switzerland, and Swiss destination rules need their own national and cantonal examination. Gather prescriber identity, required particulars, document format and any stated refusal. Dispensing, reimbursement and personal import are separate questions. The record does not rewrite a prescription or suggest a substitute treatment.
Julie by AlphaDeep is an AI legal assistant for French law: it researches official references to help answer your questions (Légifrance, case law, service-public), analyses your documents and drafts your letters, for individuals and professionals alike.
- Official texts cited
- Sources checked on
- Drafted with AI assistance, our method
General legal information with official references and dated checks. It is not personalised advice: for a decision that commits you, have your situation checked by a qualified professional.
Julie by AlphaDeep
What professional identity of the prescriber can be verified?
France: retain the prescriber’s identity, professional capacity and verifiable contact. Switzerland: collect equivalent evidence for the dispensing review; a readable translation proves neither professional authority nor the authenticity of the original prescription.
Read the referencesYour file concerns “Cross-border prescription: dispensing evidence record”. Does it concern France or Switzerland? Share the document for countries and destination and the decision you need to prepare.
3 free questions at signup. Avoid names and sensitive information.
Where was the prescription issued and where will dispensing occur?
France: record the issuing country and dispensing pharmacy; Switzerland is not an EU or EEA issuer. Switzerland: identify the issuing state and dispensing canton separately; neither direction establishes automatic reciprocal prescription recognition.
CNOP non-EU prescriptionCNOP EU prescriptionLPTh / HMG / LATer : 24, 26OMéd / VAM / OM : 51
Prescription particulars and dispensing-condition comparison
Synthetic example: fictional records. Prescription particulars and dispensing-condition comparison.
Synthetic example: fictional records · Prescription particulars and dispensing-condition comparison
- Jurisdiction
- France
- Countries and destination
- Issued in O1, dispensing in D1
- Prescriber and format
- Professional P1, original S1
- Particulars and product
- Identities I1, medicine M1
- Response and evidence
- Refusal or request R1, documents D2
The record does not rewrite a prescription or suggest a substitute treatment.
What professional identity of the prescriber can be verified?
France: retain the prescriber’s identity, professional capacity and verifiable contact. Switzerland: collect equivalent evidence for the dispensing review; a readable translation proves neither professional authority nor the authenticity of the original prescription.
CNOP non-EU prescriptionCNOP EU prescriptionLPTh / HMG / LATer : 24, 26OMéd / VAM / OM : 51
Which official provision helps explain this situation?
A cross-border prescription must be examined using both the issuing country and the destination of dispensing. EU recognition rules must not be extended automatically to Switzerland, and Swiss destination rules need their own national and cantonal examination. Gather prescriber identity, required particulars, document format and any stated refusal. Dispensing, reimbursement and personal import are separate questions. The record does not rewrite a prescription or suggest a substitute treatment.
Which patient, medicine and prescription particulars are present?
France: compare patient, date, medicine, strength, quantity and authentication actually present. Switzerland: VAM Article 51 provides general prescription-content foundations; missing particulars should be recorded rather than invented or treated as a rewritten prescription.
CNOP non-EU prescriptionCNOP EU prescriptionLPTh / HMG / LATer : 24, 26OMéd / VAM / OM : 51
Preparation reference: Prescription particulars and dispensing-condition comparison
| Preparation question | Point to verify |
|---|---|
| Where was the prescription issued and where will dispensing occur? | France: record the issuing country and dispensing pharmacy; Switzerland is not an EU or EEA issuer. Switzerland: identify the issuing state and dispensing canton separately; neither direction establishes automatic reciprocal prescription recognition. |
| What professional identity of the prescriber can be verified? | France: retain the prescriber’s identity, professional capacity and verifiable contact. Switzerland: collect equivalent evidence for the dispensing review; a readable translation proves neither professional authority nor the authenticity of the original prescription. |
| Which patient, medicine and prescription particulars are present? | France: compare patient, date, medicine, strength, quantity and authentication actually present. Switzerland: VAM Article 51 provides general prescription-content foundations; missing particulars should be recorded rather than invented or treated as a rewritten prescription. |
| What recognition or destination rules govern that country pair? | France: the professional-order guide distinguishes EU and non-EU prescriptions and bounded discretionary dispensing. Switzerland: HMG Articles 24 and 26 do not alone establish nationwide foreign-prescription recognition; the current destination-canton position remains to be verified. |
CNOP non-EU prescriptionCNOP EU prescriptionLPTh / HMG / LATer : 24, 26OMéd / VAM / OM : 51
What recognition or destination rules govern that country pair?
France: the professional-order guide distinguishes EU and non-EU prescriptions and bounded discretionary dispensing. Switzerland: HMG Articles 24 and 26 do not alone establish nationwide foreign-prescription recognition; the current destination-canton position remains to be verified.
CNOP non-EU prescriptionCNOP EU prescriptionLPTh / HMG / LATer : 24, 26OMéd / VAM / OM : 51
Which paper or electronic form can actually be used?
France: identify original, copy, electronic document and translation separately. Switzerland: document the form and authentication available for the local review; possession of a screenshot does not establish every acceptance requirement.
CNOP non-EU prescriptionCNOP EU prescriptionLPTh / HMG / LATer : 24, 26OMéd / VAM / OM : 51
What availability or special-category question needs separate checking?
France: check availability and any controlled or special category without recommending medical substitution. Switzerland: apply the same separation; general prescription foundations do not settle every medicine category, availability problem or special permission.
CNOP non-EU prescriptionCNOP EU prescriptionLPTh / HMG / LATer : 24, 26OMéd / VAM / OM : 51
Which reason for non-dispensing has been communicated?
France: retain the pharmacy’s precise stated reason for non-dispensing. Switzerland: likewise distinguish missing identity, content, authenticity, availability or local-rule evidence; the existence of a foreign prescription does not itself establish an unlawful refusal.
CNOP non-EU prescriptionCNOP EU prescriptionLPTh / HMG / LATer : 24, 26OMéd / VAM / OM : 51
How are dispensing, reimbursement and personal import kept separate?
France: dispensing, reimbursement and border importation concern separate decisions. Switzerland: maintain separate evidence for each; a prescription accepted at the counter does not automatically settle payment entitlement or personal import permission.
CNOP non-EU prescriptionCNOP EU prescriptionLPTh / HMG / LATer : 24, 26OMéd / VAM / OM : 51
What other questions arise in this file?
What professional identity of the prescriber can be verified?
France: retain the prescriber’s identity, professional capacity and verifiable contact. Switzerland: collect equivalent evidence for the dispensing review; a readable translation proves neither professional authority nor the authenticity of the original prescription.
CNOP non-EU prescriptionCNOP EU prescriptionLPTh / HMG / LATer : 24, 26OMéd / VAM / OM : 51
What recognition or destination rules govern that country pair?
France: the professional-order guide distinguishes EU and non-EU prescriptions and bounded discretionary dispensing. Switzerland: HMG Articles 24 and 26 do not alone establish nationwide foreign-prescription recognition; the current destination-canton position remains to be verified.
CNOP non-EU prescriptionCNOP EU prescriptionLPTh / HMG / LATer : 24, 26OMéd / VAM / OM : 51
What availability or special-category question needs separate checking?
France: check availability and any controlled or special category without recommending medical substitution. Switzerland: apply the same separation; general prescription foundations do not settle every medicine category, availability problem or special permission.
CNOP non-EU prescriptionCNOP EU prescriptionLPTh / HMG / LATer : 24, 26OMéd / VAM / OM : 51
How are dispensing, reimbursement and personal import kept separate?
France: dispensing, reimbursement and border importation concern separate decisions. Switzerland: maintain separate evidence for each; a prescription accepted at the counter does not automatically settle payment entitlement or personal import permission.
CNOP non-EU prescriptionCNOP EU prescriptionLPTh / HMG / LATer : 24, 26OMéd / VAM / OM : 51
Which official references should you consult?
- CNOP non-EU prescriptionwww.ordre.pharmacien.fr
- CNOP EU prescriptionwww.ordre.pharmacien.fr
- LPTh / HMG / LATer : 24, 26www.fedlex.admin.ch
- OMéd / VAM / OM : 51www.fedlex.admin.ch
Texts cited last checked: 3 November 2026